Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Intestinal Wall Remodeling (Infliximab Therapy) in Crohn's Disease Patients Undergoing Serial Computed Tomography (CT) Enterography

This study has been completed.
Sponsor:
Collaborator:
Centocor Ortho Biotech Services, L.L.C.
Information provided by:
Mayo Clinic
ClinicalTrials.gov Identifier:
NCT00819663
First received: January 7, 2009
Last updated: August 17, 2011
Last verified: August 2011